MedImmune’s Ex-CEO Joins Investment Firm

| By HealthLeaders Media Staff
| September 18, 2008

The former CEO of MedImmune will become a general partner at New Enterprise Associates, a Chevy Chase venture capital firm. According to officials, David M. Mott will be working with the healthcare investment team, focusing specifically on biotechnology and specialty pharmaceuticals.

Full story

Tagged Under:

Most Popular

#1

The Ending of the Physician Era. Begin the Age of the APP.

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

AI Won't Save Healthcare. But It Will Help. If We Let It.

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...

Search form

MedImmune’s Ex-CEO Joins Investment Firm

Share this:

Tagged Under:

Most Popular

The Ending of the Physician Era. Begin the Age of the APP.

AI Won't Save Healthcare. But It Will Help. If We Let It.

Get the latest on healthcare leadership in your inbox.